Plus Therapeutics (PSTV) Gross Profit (2011 - 2019)
Plus Therapeutics (PSTV) reported Gross Profit of $589000.0 for Q1 2019, up 287.5% year-over-year from $152000.0 in Q1 2018, and down 57.16% quarter-over-quarter from $1.4 million in Q4 2018.
Plus Therapeutics (PSTV) Gross Profit (2011 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has 9 years of Gross Profit data on file, last reported at $589000.0 in Q1 2019.
- Gross Profit for Q1 2019 came in at $589000.0, up 287.5% year-over-year; the trailing twelve-month figure through Mar 2019 was $2.2 million (up 425.77% YoY), and the FY2018 annual result was $3.0 million, up 1973.97% from the prior year.
- Gross Profit slipped to $589000.0 in Q1 2019 per PSTV's latest filing, from $1.4 million in the prior quarter.
- Over five years, Gross Profit peaked at $1.4 million in Q4 2018 and troughed at -$125000.0 in Q1 2017.
- A 5-year average of $359705.9 and a median of $264000.0 in 2015 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2017 and 2018: Gross Profit plunged 117.7% in 2017, then jumped 4641.38% in 2018.
- A 5-year view of Gross Profit shows it stood at $765000.0 in 2015, then slumped by 31.9% to $521000.0 in 2016, then tumbled by 94.43% to $29000.0 in 2017, then jumped by 4641.38% to $1.4 million in 2018, then plunged by 57.16% to $589000.0 in 2019.
- Business Quant data shows PSTV's Gross Profit at $589000.0 in Q1 2019, $1.4 million in Q4 2018, and $230000.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 589,000.00 |
| Mar 31, 2019 | 589,000.00 |
| Dec 31, 2018 | 1.38 Mn |
| Dec 31, 2018 | 1.38 Mn |
| Sep 30, 2018 | 230,000.00 |
| Sep 30, 2018 | 230,000.00 |
| Jun 30, 2018 | 30,000.00 |
| Jun 30, 2018 | 30,000.00 |
| Mar 31, 2018 | 152,000.00 |
| Mar 31, 2018 | 152,000.00 |
| Dec 31, 2017 | 29,000.00 |
| Dec 31, 2017 | 29,000.00 |
| Sep 30, 2017 | -20,000.00 |
| Sep 30, 2017 | -20,000.00 |
| Jun 30, 2017 | 262,000.00 |
| Jun 30, 2017 | 262,000.00 |
| Mar 31, 2017 | -125,000.00 |
| Mar 31, 2017 | -125,000.00 |
| Dec 31, 2016 | 521,000.00 |
| Dec 31, 2016 | 521,000.00 |